143,548 Shares in Syneron Medical Ltd. (ELOS) Acquired by GLG Partners LP
GLG Partners LP acquired a new position in shares of Syneron Medical Ltd. (NASDAQ:ELOS) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 143,548 shares of the medical equipment provider’s stock, valued at approximately $1,572,000.
A number of other large investors also recently modified their holdings of ELOS. Vivaldi Asset Management LLC acquired a new stake in Syneron Medical in the 2nd quarter valued at about $9,644,000. Citadel Advisors LLC raised its stake in shares of Syneron Medical by 2.1% in the first quarter. Citadel Advisors LLC now owns 11,835 shares of the medical equipment provider’s stock worth $125,000 after acquiring an additional 243 shares during the last quarter. Airain ltd bought a new position in shares of Syneron Medical in the second quarter worth about $1,095,000. Goldman Sachs Group Inc. raised its stake in shares of Syneron Medical by 47.9% in the first quarter. Goldman Sachs Group Inc. now owns 52,213 shares of the medical equipment provider’s stock worth $551,000 after acquiring an additional 16,910 shares during the last quarter. Finally, Mizuho Securities USA LLC bought a new position in shares of Syneron Medical in the second quarter worth about $5,037,000. 69.17% of the stock is currently owned by hedge funds and other institutional investors.
Separately, BidaskClub cut shares of Syneron Medical from a “hold” rating to a “sell” rating in a research note on Thursday, July 6th.
Syneron Medical Ltd. (NASDAQ:ELOS) remained flat at $11.00 during midday trading on Wednesday. The company’s stock had a trading volume of 3,905 shares. Syneron Medical Ltd. has a 52-week low of $6.18 and a 52-week high of $11.43. The company has a 50 day moving average of $10.90 and a 200-day moving average of $10.14.
Syneron Medical Company Profile
Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.
Receive News & Ratings for Syneron Medical Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.